SAMHD1 and Aicardi-Goutieres syndrome: An examination of several SAMHD1 mutants that have been identified in AGS patients indicated that they all show significantly reduced LINE-1 inhibition (p < 0.01 versus wild-type SAMHD1), even when expressed at levels comparable to wild-type SAMHD1 (Figures 2B and 2C).